{"id":"W4379280787","doi":"10.1200/jco.2023.41.16_suppl.9579","title":"A pilot study of the neoadjuvant use of vemurafenib plus cobimetinib in patients with BRAF-mutant melanoma with palpable lymph node metastases: Survival results.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre; McGill University; Ottawa Hospital; Jewish General Hospital; University of Ottawa; Royal Victoria Hospital; Health Sciences Centre; Sunnybrook Hospital","funders":"","keywords":"Medicine; Vemurafenib; Melanoma; Internal medicine; Neoadjuvant therapy; Lymph node; Surgery; Oncology; Cancer; Metastatic melanoma; Breast cancer; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001741522,0.001018989,0.001490071,0.0003233187,0.0004278649,0.0006502143,0.0004902135,0.0007789127,0.00216558],"category_scores_gemma":[0.001444207,0.0004705067,0.001305847,0.0003694639,0.0007171627,0.0008321441,0.0003894414,0.001480558,0.0005835532],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007707616,"about_ca_system_score_gemma":0.001098015,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001100574,"about_ca_topic_score_gemma":0.0018336,"domain_scores_codex":[0.9992286,0.0004115719,0.00004128867,0.0001342707,0.00005379822,0.0001303461],"domain_scores_gemma":[0.9983667,0.0003642428,0.0002927095,0.0001234289,0.00008988087,0.0007632279],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7794489,0.07732164,0.07788841,0.0002746416,0.0009097799,0.0004114024,0.0003966036,0.001125198,0.02019015,0.00006481422,0.0006400143,0.04132849],"study_design_scores_gemma":[0.06159656,0.8404722,0.09436857,0.00001643236,0.0004316852,0.0002348709,0.0001134327,0.0006649924,0.001246086,0.00004355988,0.0007812987,0.00003031033],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.998711,0.0002834765,0.0001071966,0.0000537375,0.00002261532,0.0003257236,0.0002106054,0.00000895315,0.0002766395],"genre_scores_gemma":[0.9975845,0.0002489611,0.0004401061,0.0001365763,0.00009859216,0.0004990448,0.0005290842,0.00000522208,0.0004579536],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00216558,"threshold_uncertainty_score":0.009210169,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09954392322007363,"score_gpt":0.3546250095458915,"score_spread":0.2550810863258179,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}